Article ID Journal Published Year Pages File Type
6182943 Gynecologic Oncology 2012 12 Pages PDF
Abstract
► Genetic polymorphisms are potential biomarkers in the treatment of gynecological malignancies. ► Associations between treatment outcome and polymorphisms in ERCC1, VEGF and MDR warrant further study. ► Validation of genetic biomarkers in clinical trials and adherence to REMARK guidelines is crucial to move the field forward.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Obstetrics, Gynecology and Women's Health
Preview
Genetic polymorphisms as predictive and prognostic biomarkers in gynecological cancers: A systematic review
Authors
, , , , ,